ZNF738 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.067900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.127390E-01
Normal-vs-Stage2
4.293900E-02
Normal-vs-Stage3
1.262560E-01
Normal-vs-Stage4
1.762800E-01
Stage1-vs-Stage2
8.455200E-01
Stage1-vs-Stage3
5.435800E-01
Stage1-vs-Stage4
8.804200E-01
Stage2-vs-Stage3
3.133600E-01
Stage2-vs-Stage4
9.862400E-01
Stage3-vs-Stage4
5.164800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.482500E-02
Normal-vs-AfricanAmerican
7.982000E-02
Normal-vs-Asian
1.115050E-01
Caucasian-vs-AfricanAmerican
2.895200E-01
Caucasian-vs-Asian
6.967800E-01
AfricanAmerican-vs-Asian
5.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.052100E-02
Normal-vs-Female
3.003700E-02
Male-vs-Female
7.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.338200E-01
Normal-vs-Age(41-60Yrs)
3.046000E-02
Normal-vs-Age(61-80Yrs)
6.004300E-02
Normal-vs-Age(81-100Yrs)
2.394100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.819230E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.411800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.576000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.913800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.355590E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.068300E-02
Normal-vs-Daily Drinker
4.606400E-02
Normal-vs-Weekly Drinker
6.447900E-02
Normal-vs-Occasional Drinker
2.801900E-02
Normal-vs-Social Drinker
5.009900E-02
Non Drinker-vs-Daily Drinker
9.737600E-01
Non Drinker-vs-Weekly Drinker
6.748600E-01
Non Drinker-vs-Occasional Drinker
9.336800E-01
Non Drinker-vs-Social Drinker
7.814200E-01
Daily Drinker-vs-Weekly Drinker
6.335600E-01
Daily Drinker-vs-Occasional Drinker
9.550200E-01
Daily Drinker-vs-Social Drinker
7.408400E-01
Weekly Drinker-vs-Occasional Drinker
5.912800E-01
Weekly Drinker-vs-Social Drinker
8.817200E-01
Occasional Drinker-vs-Social Drinker
6.931400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.784200E-01
Normal-vs-Grade 2
3.199700E-02
Normal-vs-Grade 3
5.466000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.051800E-01
Grade 1-vs-Grade 3
5.036800E-01
Grade 1-vs-Grade 4
1.784200E-01
Grade 2-vs-Grade 3
2.757600E-01
Grade 2-vs-Grade 4
3.199700E-02
Grade 3-vs-Grade 4
5.466000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.373700E-02
Normal-vs-NonDiabetic
3.676400E-02
Diabetic-vs-NonDiabetic
9.619800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.454180E-01
Normal-vs-NoPancreatitis
2.684000E-02
Pancreatitis-vs-NoPancreatitis
8.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.454100E-02
Normal-vs-N1
4.324000E-02
N0-vs-N1
5.867200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.072620E-01
Normal-vs-TP53-NonMutant
4.657600E-02
TP53-Mutant-vs-TP53-NonMutant
7.229900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
